EUVIMEDEUVIMED entdecken
Crossref

Oral Vitamin E for Vasomotor Symptoms in Menopause: An Evidence-based Symptom-Management Project

Mara Simmons, Carol Lawrence

Aquila: The FGCU Student Research Journal · 2026 · 10 (1) · 1-13

DOI: 10.24049/aq.10.1.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aquila: The FGCU Student Research Journal, 2026. Verfasst von Mara Simmons und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menopause, clinically defined as the permanent cessation of menstruation for twelve consecutive months, is a natural transition experienced by over one million women annually in the United States (Feduniw et al., 2022). Up to 80% of menopausal women experience vasomotor symptoms, notably hot flashes and night sweats, which significantly impair daily functioning, sleep, and overall quality of life (Yousefi-Nodeh et al., 2022). While hormone replacement therapy has been considered the gold standard for managing these symptoms, it is not suitable for all women due to contraindications or personal preferences. Non-hormonal therapy options remain limited and underutilized in the treatment of vasomotor symptoms, highlighting a significant gap in care (American College of Obstetricians and Gynecologists [ACOG], 2014).Nurses are essential in addressing this gap, as they are uniquely positioned to educate and guide women through menopausal management options. In alignment with Provision 4 of the American Nurses Association’s Code of Ethics (2015), which emphasizes the responsibility to promote health and provide optimal care through evidence-based practice, nurses play a vital role in offering individualized, nonpharmacologic interventions that support quality of life during this transition. The purpose of this evidence-based project was to evaluate the current evidence on oral vitamin E supplementation for reducing hot flashes in menopausal women and to provide recommendations for its translation into nursing practice. This review examines the current evidence regarding oral vitamin E supplementation for the management of vasomotor symptoms in menopausal women. Specifically, the literature explores three key areas: the effectiveness of vitamin E in reducing the frequency and severity of vasomotor symptoms, dosing ranges across studies, and clinical considerations for safe implementation into nursing practice. Vitamin E dosing in the literature is reported using both International Units (IU) and milligrams (mg), which complicates interpretation across studies. Conversion between IU and mg depends on the formulation of vitamin E, as natural (d-alpha-tocopherol) and synthetic (dl-alpha-tocopherol) preparations differ in biologic potency. One mg of alpha-tocopherol is equivalent to 1.49 IU of the natural form or 2.22 IU of the synthetic form. Conversely, one IU of natural vitamin E equals approximately 0.67 mg of alpha-tocopherol, while one IU of the synthetic form equals approximately 0.45 mg (National Institutes of Health [NIH], 2021). Most studies included in this review did not specify whether vitamin E was administered in natural or synthetic form, limiting direct dose equivalency comparisons. To preserve accuracy and transparency, vitamin E doses in this project are reported as published in the original studies, with unit variability acknowledged as a limitation.

Zitieren

APA

Simmons, M., & Lawrence, C. (2026). Oral Vitamin E for Vasomotor Symptoms in Menopause: An Evidence-based Symptom-Management Project. Aquila: The FGCU Student Research Journal, 10(1), 1-13. https://doi.org/10.24049/aq.10.1.1

Vancouver

Simmons M, Lawrence C. Oral Vitamin E for Vasomotor Symptoms in Menopause: An Evidence-based Symptom-Management Project. Aquila: The FGCU Student Research Journal. 2026;10(1):1-13. doi:10.24049/aq.10.1.1

BibTeX
@article{Simmons2026,
  author = {Simmons, Mara and Lawrence, Carol},
  title = {Oral Vitamin E for Vasomotor Symptoms in Menopause: An Evidence-based Symptom-Management Project},
  journal = {Aquila: The FGCU Student Research Journal},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {1--13},
  doi = {10.24049/aq.10.1.1}
}
Kostenlos starten →